Biotechnology

RXi Improves Losses $RXII $XHS

RXi Pharmaceuticals., has announced its first quarter results for FY-2015. The results shows revenues of $34,000 up by +17.2% and Loss Per Share -$0.13 improves by 59.4% YoY. View the full earnings release here.

Icon Revenues Up $ICLR $XHS

ICON plc, a global provider of pharmaceutical, biotechnology and medical devices, , has announced its financial results for the first quarter 2015. The results shows Revenues Rise to $388.2 Million at +11.0% and EPS was $0.9 up by +57.9%. View the full earnings release here.

Sinovac Revenues Down $SVA $XHS

Sinovac Biotech has announced its annual financial results of FY-14. The results Shows that Sales downs 13%, Gross Profit down 9.1% and Net Income (EPS) of $0.13 went down to Loss at -$0.02. View the full earnings release here.